Newmed Energy Limited Partnership · TASE:NWMD
Newmed Energy Limited Partnership — Q1 2025 Earnings Presentation
17 slides from Newmed Energy Limited Partnership's earnings presentation, May 2025
Slide 1: 1Q 2025 Financial Results Presentation
Slide 2: Disclaimer
NA Disclaimer This presentation was prepared by NewMed Energy Limited Partnership (the "Partnership") based on information included in the immediate and periodic reports filed by the Partnership with the Israel Securities Authority and the Tel Aviv Stock Exchange Ltd. under the Securities Law, 5728-
Slide 3: Quarter highlights
Q 4s“ quarter gas sales - 1,156 MMcf/d (203 Mboe/d), 2.9 BCM Q 1% quarter earnings - $201mm EBITDA / $116mm net profit Q Leviathan operational Update & Phase 1B Expansion Q Additional Upstream Activities : = Cyprus Aphrodite : FDP approved = Bulgaria Han-Asparuh Exploration Q Financing : $400 mm Lev
Slide 4: Production Summary
Production Summary. Average Price ($/mmbtu) 5.85 Average Price ($/mmbtu) 616 * Production Summary for Leviathan 100%
Slide 5: Production and price chart
140. 8.00 120. 6.00 100. 80. 4.00 60. 40. 2.00 20. 0. 0.00
Slide 6: Leviathan Operational Update
Leviathan Operati Q Phase 1B Expansion — working in 3 main channels in order to reach a Final Investment Decision in the near future : = Engineering & Design — FEED underway including procurement items. Finalizing schedule and budget for FID = Regulatory - Phase 1B updated FDP + Export permit green
Slide 7: Regional Connectivity Update
Regional Connectivity Update Leviathan Connecti pipeline to Jordan @ INGL Ashdod-Ashkelon, EMG pipeline Debottleneck using Full capacity of EMG - 800mme/d — 1H 2026 transmission system @ FAJR + compression — Additional 400 mmcef/d — 2H 2026 Mediterranean Sea INGL Ashdod-Ashkelon pipeline (3) Nitzana
Slide 8: Additional Upstream Activities
N Additional Upstream Activities Aphrodite FDP approved by MECI. Partners approved budget of $20mm for examining the construction of transmission infrastructure from the Aphrodite reservoir Cyprus Mediterranean Sea Aphrodite Block 12 » D: ae Alexandria ® Idku so hiae Bulgaria—§ Han-Asparuh Farm-in a
Slide 9: Sales, EBITDA and Net Profit
st . . . Sales EBITDA Net Profit 281 263 : 10 23 1024 1025 19 28 10.24 1925 10 23 10 24 1025 EBITDA calculated as Operating profit + Deprecation and Amortization
Slide 10: Income statement
* Less than $0.1mm Revenues From natural gas and condensate sales Net of royalties Revenues, net Expenses and costs: Cost of production of natural gas and condensate Depreciation, depletion and amortization expenses Other direct expenses Gea Total expenses and costs The Partnership's share in the lo
Slide 11: 1st Quarter Change in Net Profit
1st Quarter Change in Net Profit (smm) 121.1 Net profit Q1.2024 10.3 Price per mmbtu 25.9 Change in Quantities 39 Condensate Sale -23.5 Net Financeial Expense Operating Expense 03 Tax Expense 116.4 Net profit Q1.2025 n
Slide 12: Financial Debt
NA Financial Debt ss) OQ Leviathan Bond June-25 series partial pre-payment of $400mm. Remaining balance of $200 mm to be paid at the end of June QQ NewMed's Leviathan Bond buy back amounts to $154mm to date. OQ Prudent financial management to support expansion investment. The partnership is explorin
Slide 13: Balance Sheet
NN Assets: Current assets: Cash and cash equivalents 99.7 152.3 51.2 Short-term deposits 337.7 89.5, 333.3 Trade receivables 226.2 226.1 209.6 Trade and other receivables 124.6 146.3 140.0 788.2 614.2 734.1 Balance Sheet Non-current assets: Investments in oil and gas assets 2,703.1 2,645.5 Investmen
Slide 14: $60mm profit distribution for the quarter
Q $60mm profit distribution for the quarter Q Committed to delivering share-holders returns through dividend distributions. Dividend Distributions 100 65 65 10 20 30 4Q 10 20 30 4Q 10 20 30 4Q 10 20 30 40 10 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025 * Inclu
Slide 15: Contact: IR@newmedenergy.com
—— = = IR@newmedenergy.com
Slide 16: Appendix
Slide 17: Leviathan Bond Sponsor Financial Data Report
Leviathan Bond Sponsor FinancialDataReport Total offtake (BCM) and Leviathan Revenue for 100% of the Leviathan partners on an accrual basis. RTER ENDED AMOUNT (IN USD$ ,000) Total Offtake (BCM) Leviathan Revenues (100%) 634,220 Loss Proceeds, if any, paid to Revenue Account - Sponsor Deposits, if an
NewMed Energy Limited Partnership — Q1 2025 Earnings Presentation on 6ix